LONDON, September 4, 2012 /PRNewswire/ --
USP published their long awaited new drafts to revise the General Chapters 41 "Balances" and 1251 "Weighing on an Analytical Balance" in the Pharmacopeial Forum PF 38(5).
The new drafts are intended to replace the existing chapters and provide a more user-friendly option for the determination of minimum weight. The documents also propose a risk-based approach to determine type and frequency of routine tests, with the omission of daily balance checks from the drafts in accordance with current FDA thinking.
In response to the updated drafts, Dr Klaus Fritsch, Manager Compliance, Global Business Area Laboratory & Weighing Technologies at METTLER TOLEDO presents a contemporary strategy for best-practice compliance with these new guidelines following Good Weighing Practice™; the global Weighing Standard.
In addition to his role at METTLER TOLEDO, Dr Fritsch frequently consults the industry to help achieve compliance with applicable regulations when using weighing systems. He has been actively involved on committees including the USP Expert Panel to revise the General Chapters 41 and 1251.
In his presentation, Dr Fritsch explains how these revised chapters affect balance quality management and applicable SOPs, especially in the framework of determining minimum weight and executing routine testing.
- In depth information on the new requirements of the draft to change USP General Chapter 41 "Balances"
- Which tests have to be periodically performed on balances used for quantitative analysis and which acceptance criteria apply
- The two alternatives to assess and calculate the minimum weight of your balances
- Insight into the risk-based approach to performing balance routine testing as recommended by USP General Chapter 1251 "Weighing on an Analytical Balance"
- The proper weight selection for balance routine testing
- Why the General Chapters no longer talk about daily balance checks
The full presentation can be viewed exclusively at Pharma IQ now:
GWP® is the only science-based global standard for efficient lifecycle management of weighing systems, developed from the expertise of METTLER TOLEDO. Lifecycle management according to GWP consists of evaluation, selection, installation, calibration and routine operation. GWP is applicable to all kinds of weighing systems of any manufacturer!
Based on the sound scientific principles of the global weighing standard, METTLER TOLEDO offers two unique commercial services: GWP® Verification & GWP® Recommendation. Service offerings, which guarantee consistent weighing accuracy, audit readiness and feasible cost efficiency, encompassing the entire lifecycle of the weighing equipment http://www.mt.com/gwp
About Mettler Toledo
METTLER TOLEDO is a global manufacturer and marketer of precision instruments for use in laboratory, industrial and food retailing applications. The Company has strong worldwide leadership positions. A significant majority of METTLER TOLEDO instrument sales are in segments in which METTLER TOLEDO is the global leader. In addition to a broad product offering, METTLER TOLEDO has one of the largest global sales and service organizations among precision instrument companies. http://www.mt.com
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community.
Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical executives to network and learn the latest pharma business development and trends occurring in organizations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma industry leaders. http://www.Pharma-IQ.com
IQPC Ltd has an established reputation for delivering the highest standard of industry specific conferences, seminars and internal training programmes. We aim to keep business executives up-to date with the forefront of their industries' trends, technological developments and regulatory landscape.
SOURCE Pharma IQ